Suppr超能文献

绝经后妇女牙种植体的临床结果及骨标志物变化:一项为期一年的前瞻性研究。

Clinical outcomes and bone marker changes in postmenopausal women with dental implants: a one-year prospective study.

作者信息

Cho Jung Min, Hong Namki, Rhee Yumie, Park Wonse, Oh Kyung Chul, Seo Yanggyung, Lee Hwangyu, Jo Hyeon-Gyu, Shin Yunji, Kim Jun-Young

机构信息

Department of Oral and Maxillofacial Surgery and Oral Science Research Center, Yonsei University College of Dentistry, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.

Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Int J Implant Dent. 2025 May 24;11(1):41. doi: 10.1186/s40729-025-00628-4.

Abstract

OBJECTIVES

The feasibility of dental implants in patients with osteoporosis remains controversial, with limited prospective studies on quantitative changes in bone mineral density (BMD) and bone turnover markers (BTMs). This study assessed implant survival and clinical outcomes while evaluating systemic changes during 1 year of implant treatment.

MATERIALS AND METHODS

Postmenopausal women requiring dental implants were enrolled at the Yonsei University Dental Hospital. BMD and BTMs were evaluated in collaboration with the endocrinology department. Participants were divided into two groups: Group A (T-score ≥ -2) and Group B (T-score < -2). All implants used in the study were surface-treated with hydroxyethyl piperazine ethane sulfonic acid (HEPES), and clinical, radiographic, and systemic parameters were monitored for over 1 year.

RESULTS

Between April 2022 and May 2024, 45 implants were placed in 36 patients (mean age: 68 years). Group A included 17 patients with 21 implants (mean age: 66 years), and Group B included 19 patients with 24 implants (mean age: 70 years). The cumulative survival rate was 100%. Resonance frequency analysis at 12 months revealed a mean implant stability tester value of 71.4 ± 5.52, indicating excellent osseointegration. Peri-implant bone loss averaged 0.54 ± 0.35 mm. No implant failures occurred, with stable plaque scores, probing depths, and bleeding upon probing. BMD and BTMs changes were minimal.

CONCLUSIONS

Both groups achieved high implant survival and stable clinical outcomes. Systemic evaluations confirmed only minor changes in BMD and BTMs over 1 year. Larger multicenter studies are required to confirm the systemic safety of dental implants in patients with osteoporosis.

CLINICAL RELEVANCE

Dental implants show excellent survival and stability in postmenopausal women with osteoporosis, with minimal impact on bone density and turnover-supporting their safe use in this population.

CLINICAL TRIAL REGISTRATION

This study was prospectively registered at the Clinical Research Information Service of the National Research Institute of Health, Republic of Korea (KCT0007100). The registration details can be accessed at https://cris.nih.go.kr .

摘要

目的

骨质疏松症患者植入牙种植体的可行性仍存在争议,关于骨密度(BMD)和骨转换标志物(BTMs)定量变化的前瞻性研究有限。本研究评估了种植体的存活率和临床结果,同时评估了种植治疗1年期间的全身变化。

材料与方法

延世大学牙科学院医院招募了需要植入牙种植体的绝经后女性。与内分泌科合作评估骨密度和骨转换标志物。参与者分为两组:A组(T值≥ -2)和B组(T值< -2)。本研究中使用的所有种植体均用羟乙基哌嗪乙烷磺酸(HEPES)进行表面处理,并对临床、影像学和全身参数进行了1年以上的监测。

结果

在2022年4月至2024年5月期间,36例患者(平均年龄:68岁)植入了45颗种植体。A组包括17例患者,植入21颗种植体(平均年龄:66岁),B组包括19例患者,植入24颗种植体(平均年龄:70岁)。累积存活率为100%。12个月时的共振频率分析显示,种植体稳定性测试仪的平均数值为71.4±5.52,表明骨结合良好。种植体周围骨吸收平均为0.54±0.35毫米。未发生种植体失败,菌斑评分、探诊深度和探诊出血均稳定。骨密度和骨转换标志物的变化极小。

结论

两组均实现了较高的种植体存活率和稳定的临床结果。全身评估证实,1年内骨密度和骨转换标志物仅有微小变化。需要开展更大规模的多中心研究,以确认牙种植体在骨质疏松症患者中的全身安全性。

临床意义

牙种植体在患有骨质疏松症的绝经后女性中显示出优异的存活率和稳定性,对骨密度和骨转换的影响极小,支持在该人群中安全使用。

临床试验注册

本研究已在大韩民国国立卫生研究院临床研究信息服务中心进行前瞻性注册(KCT0007100)。可通过https://cris.nih.go.kr访问注册详情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cb/12103401/18090a23d199/40729_2025_628_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验